A Pilot Study of Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma
Latest Information Update: 10 Feb 2025
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
Most Recent Events
- 07 Feb 2025 Planned End Date changed from 31 Dec 2024 to 31 Dec 2025.
- 07 Feb 2025 Planned primary completion date changed from 31 Dec 2024 to 31 Dec 2025.
- 21 Dec 2024 Planned primary completion date changed from 22 Jun 2024 to 31 Dec 2024.